Express Scripts ESRX
-
Express Scripts Holding (ESRX) is less than two months into digesting its massive Medco purchase but is already seeing some early benefits. From the large (lower-priced deals from manufacturers) to ...
Express Scripts Holding ( ESRX ) is less than two months into digesting its massive Medco purchase but is already seeing some early benefits …
-
Express Scripts (ESRX) CEO George Paz tells the WSJ that he would "love to do a deal with Walgreen (WAG)" to revive their contract, which expired a few months ago, "if they're willing to offer rates ...
Express Scripts ( ESRX ) CEO George Paz tells the WSJ that he would "love to do ..... with everybody else." Of the Medco merger, Paz said that while Express Scripts is frugal, Medco "had a different culture with respect to spending …
-
Specialty drug costs a major employer worry-survey
May 17 (Reuters) - Employers want to step up programs to encourage healthier behavior among their workers and to control spending on expensive injected specialty medicines, according to a survey by pharmacy benefit manager Express Scripts Holding Co .
-
New Morningstar Analyst Report - CVS Caremark Corporation
… sharp contrast to peers Medco and Express Scripts . Recent contract repricing could ..... including future reimbursement pressure. Express Scripts has become a much stronger competitor ..... beneficiary of the dispute between Express Scripts and Walgreen, gaining retail market …
-
Express Scripts Holding's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Express Scripts Holding ( ESRX ) Q1 2012 Earnings Call May 11, 2012 9:00 am ET ..... Ladies and gentlemen, thank you for standing by, and welcome to the Express Scripts First Quarter 2012 Earnings Call. [Operator Instructions] And …
-
Express shares up; Walgreen, outlook worries fade
(Reuters) - Shares of Express Scripts Holding Co rose nearly 4 percent on Friday as investors shrugged off concerns about the U.S. pharmacy benefit manager's financial outlook and ability to...
-
Express Scripts Feels No Impact from Walgreen Dispute in 1Q
Express Scripts ESRX appears on pace to meet our ..... this range. We continue to see Express Scripts as undervalued relative to our ..... dispute, reinforcing our thesis that Express Scripts has a much stronger bargaining position …
-
Express Scripts ESRX Q1 2012 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Express Scripts ' First Quarter 2012 Earnings Conference Call. For the conference, all participants are in a listen-only mode. As a reminder …
-
Express Scripts outlook could fall short of Street
May 10 (Reuters) - Express Scripts Holding Co projected full-year profit that could fall short of Wall Street's target in the U.S. pharmacy benefit manager's first forecast since closing its $29...
-
Express Scripts (ESRX): Q1 EPS of $0.73 misses by $0.04. Revenue of $12.1B beats by beats b $660M. (PR)
Express Scripts ( ESRX ): Q1 EPS of $0.73 misses by $0.04 . Revenue of $12.1B beats by beats b $660M . ( PR ) Post your comment!